ProGnosis Biotech against COVID-19

3/2020

ProGnosis Biotech against COVID-19

As WHO has declared the coronavirus outbreak a pandemic, we all are responsible for taking preventive measures to limit its spread. We are all responsible as well for helping our communities to tackle the problem by giving solutions or at least by trying to unite our efforts towards this direction.

ProGnosis Biotech, the sole biotechnology company in Greece with prime focus on producing efficient rapid diagnostic tests for the identification of toxins, feels the duty to contribute to the worldwide efforts that have been made so far and does not want to be just an observer against this threat. Our solid scientific background and know-how in immunoassays (Elisa and Lateral Flow) will be used for the development of rapid methods for the detection of COVID-19.

Our R&D department and everyone working in our company is dedicated to this higher goal of combating COVID-19 and we believe that it is the least we can do.